Title 21

PART 250

Part 250 - Special Requirements For Specific Human Drugs

PART 250 - SPECIAL REQUIREMENTS FOR SPECIFIC HUMAN DRUGS Authority:21 U.S.C. 321, 336, 342, 352, 353, 355, 361(a), 362(a) and (c), 371, 375(b). Source:40 FR 14033, Mar. 27, 1975, unless otherwise noted.

• Authority: 21 U.S.C. 321, 336, 342, 352, 353, 355, 361(a), 362(a) and (c), 371, 375(b).
• Source: 40 FR 14033, Mar. 27, 1975, unless otherwise noted.

21:4.0.1.1.16.1	SUBPART A	Subpart A - Drugs Regarded as Misbranded
21:4.0.1.1.16.1.1.1	SECTION 250.11	250.11 Thyroid-containing drug preparations intended for treatment of obesity in humans.
21:4.0.1.1.16.1.1.2	SECTION 250.12	250.12 Stramonium preparations labeled with directions for use in self-medication regarded as misbranded.
21:4.0.1.1.16.2	SUBPART B	Subpart B - New Drug or Prescription Status of Specific Drugs
21:4.0.1.1.16.2.1.1	SECTION 250.100	250.100 Amyl nitrite inhalant as a prescription drug for human use.
21:4.0.1.1.16.2.1.2	SECTION 250.101	250.101 Amphetamine and methamphetamine inhalers regarded as prescription drugs.
21:4.0.1.1.16.2.1.3	SECTION 250.102	250.102 Drug preparations intended for human use containing certain “coronary vasodilators”.
21:4.0.1.1.16.2.1.4	SECTION 250.103-250.104	250.103-250.104 [Reserved]
21:4.0.1.1.16.2.1.5	SECTION 250.105	250.105 Gelsemium-containing preparations regarded as prescription drugs.
21:4.0.1.1.16.2.1.6	SECTION 250.106-250.107	250.106-250.107 [Reserved]
21:4.0.1.1.16.2.1.7	SECTION 250.108	250.108 Potassium permanganate preparations as prescription drugs.
21:4.0.1.1.16.3	SUBPART C	Subpart C - Requirements for Drugs and Foods
21:4.0.1.1.16.3.1.1	SECTION 250.201	250.201 Preparations for the treatment of pernicious anemia.
21:4.0.1.1.16.4	SUBPART D	Subpart D - Requirements for Drugs and Cosmetics
21:4.0.1.1.16.4.1.1	SECTION 250.250	250.250 Hexachlorophene, as a component of drug and cosmetic products.

---